Becton Dickinson & Co. Deposit Repr 1/20th Cum Conv Pfd Registered Series A

Becton, Dickinson & Co. engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Becton, Dickinson and Co.

Within the United States, Becton Dickinson's (BDX) Diagnostic Systems unit witnessed strong revenue growth in the fiscal fourth quarter.

Becton Dickinson (BDX) Earnings Surpass Estimates in Q4

  Shares of Becton, Dickinson (NYSE:BDX) were flat in pre-market trading after the company reported Q4 results.

Recap: Becton, Dickinson Q4 Earnings

FRANKLIN LAKES, N.J., Nov. 5, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.784 billion for the fourth fiscal quarter ended September 30, 2020. This represents an increase of 4.4%...

BD Announces Fiscal Fourth Quarter And Full Year 2020 Results; Provides Fiscal 2021 Guidance

Becton, Dickinson's (BDX) fiscal fourth-quarter results likely to reflect robust performance at BD Life Sciences.

What's in Store for Becton, Dickinson's (BDX) Q4 Earnings?

BD (BDX) receives CE mark for its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor Plus System.

BD Gets CE Mark for Point-of-Care Coronavirus Antigen Test

This comes less than three months after the company received an emergency use authorization for the test from the FDA.

Becton, Dickinson Wins Designation Allowing European Sales of Coronavirus Test

A new coronavirus test that delivers results in just 15 minutes will be available in Europe next month, New Jersey-based medical-device maker Becton Dickinson announced Wednesday. The company expects to start selling its rapid COVID-19 test in the European Union countries by the end of October now that it’s met the requirements to launch the.

Becton Dickinson’s 15-minute COVID-19 test cleared for use in Europe

A rapid test to detect Covid-19 has been given the greenlight in Europe, according to its maker Becton Dickinson.

15-minute coronavirus test gets the green light for a European rollout

Medical-testing firm Becton Dickinson says it’s investigating false-positive coronavirus test results reported at nursing homes around the US.

Medical firm probes false-positive COVID-19 tests in US nursing homes

Becton Dickinson Trying To Leverage COVID-19 Opportunities While Fixing Some Longer-Term Issues

Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock?

Becton Dickinson (BDX) Down 9.8% Since Last Earnings Report: Can It Rebound?

Investors had high hopes for its rapid-response COVID-19 test.

Why Shares of Becton, Dickinson Rose 17.6% in July

Becton, Dickinson and Company (BDX) CEO Tom Polen on Q3 2020 Results - Earnings Call Transcript

Within the United States, Becton Dickinson's (BDX) Diagnostic Systems unit witnessed strong revenue growth in Q3.

Becton Dickinson (BDX) Earnings Surpass Estimates in Q3

Becton, Dickinson (BDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Becton, Dickinson (BDX) Might Surprise This Earnings Season

Becton, Dickinson's (BDX) fiscal third-quarter results likely to reflect robust performance at BD Life Sciences. However, forex is likely to have remained a woe.

What's in Store for Becton, Dickinson's (BDX) Q3 Earnings?

The company obtained Emergency Use Authorization for its coronavirus test in early July.

Becton, Dickinson Receiving $24 Million Federal Investment to Ramp Up Coronavirus Test Kit Manufacturing

Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Becton Dickinson (BDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

The company says most of these will be filled by the end of this year.

Becton, Dickinson Reports Coronavirus-Related Surge in Injection Equipment Orders From U.S. and Canada

QuidelOrtho Corp

Distribution of rapid point-of-care diagnostic instruments from Quidel and Becton, Dickinson will begin next week.

Federal Government to Send Millions of COVID-19 Tests to Nursing Homes

Becton Dickinson and Co. BDX, 1.39% said Wednesday that the U.S. government plans to buy 750,000 of the company's COVID-19 antigen diagnostic tests.

BD to sell 750,000 coronavirus tests to U.S. government

Becton, Dickinson Inc (NYSE:BDX) was trading 1.6% higher from the previous closing price.

Insider Sells Becton, Dickinson's Stock

Becton Dickinson & Co. said Wednesday that it will receive $42 million from the U.S. government to build out manufacturing capacity for vaccine injection devices, to be used during the coronavirus pandemic.

BD to get $42 million to manufacture vaccine injection devices

American Airlines

Delta Air Lines

JetBlue Airways

Southwest Airlines

United Continental Hlds

Walmart

Paychex

Also, Paychex earnings disappoint, and Becton, Dickinson was granted authorization for a 15-minute COVID-19 test.

S&P 500 Falls 34 Points: Airline Stocks Fall on Federal Aid Deal; Walmart Starting Prime Competitor but Amazon Stock Stays Above $3,000

Shares of Becton Dickinson & Co.  were down 0.7% in premarket trading on Tuesday, the day after the Food and Drug Administration issued an alert about an increased risk of false-positive results for one of BD's COVID-19 diagnostic tests.

News for Becton Dickinson & Co. Deposit Repr 1/20th Cum Conv Pfd Registered Series A Stock (BDXA)